News |  Disclaimer |  Contact |  Sitemap |  Privacy Notice | 
About us  |   Business Development  |   Territories  |   Partners  |  
Ewopharma extends its ENT portfolio

Ewopharma is launching two new ENT products. The first one is for the treatment of acute otitis externa and the second one helps to prevent it.

Acute otitis externa is an inflammation of the outer ear and ear canal, also known as swimmer’s ear. The disease roughly affects 0.5% to 1% of the population per year. As mainly children are affected by acute otitis externa, the two products also strengthen  Ewopharma’s focus on pediatrics.

Infalin Duo is a drug with a novel and unique combination of ciprofloxacin (antibiotic) and fluocinolone (anti-inflammatory). The ear drops solution is manufactured by Laboratorios Salvat with whom Ewopharma has entered into a strategic partnership. Salvat is a privately-held manufacturer of specialty pharmaceuticals and holds a leading position in the Spanish ENT market.

Dry Ears is an ear-water removal and drying aid. Water is difficult to get out of the ear, but the Dry Ears jet spray has powerful surface-tension releasing properties, which quickly dislodge the trapped water from the sides of the ear canal. This allows the water to run out easily. The product has a medical device status and is manufactured by Naveh Pharma in Israel.